Prudential PLC Has $10.45 Million Holdings in Astera Labs, Inc. $ALAB

Prudential PLC boosted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 51.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 62,790 shares of the company’s stock after purchasing an additional 21,390 shares during the quarter. Prudential PLC’s holdings in Astera Labs were worth $10,446,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ALAB. Royal Bank of Canada raised its holdings in Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the period. AQR Capital Management LLC raised its holdings in Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares during the period. Empowered Funds LLC raised its holdings in Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares during the period. First Trust Advisors LP raised its holdings in Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after buying an additional 56,952 shares during the period. Finally, Brown Advisory Inc. raised its holdings in Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after buying an additional 1,977 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity

In other news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. This represents a 7.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,311,256 shares of company stock worth $477,341,446 in the last 90 days. Company insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on ALAB. Rothschild & Co Redburn began coverage on Astera Labs in a report on Friday, May 1st. They set a “neutral” rating and a $153.00 price objective on the stock. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Evercore restated an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Susquehanna boosted their price objective on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Finally, Barclays boosted their price objective on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Twelve research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Astera Labs Price Performance

Shares of ALAB opened at $317.06 on Friday. The company has a market capitalization of $54.35 billion, a price-to-earnings ratio of 214.23, a P/E/G ratio of 4.74 and a beta of 3.95. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $372.37. The business’s 50-day moving average is $212.95 and its 200-day moving average is $171.60.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.